$Hypofractionated radiotherapy after conservative surgery may increase low–intermediate grade late fibrosis in breast cancer patients$

Hypofractionated radiotherapy after conservative surgery may increase low–intermediate grade late fibrosis in breast cancer patients

Cinzia Digesù,1 Francesco Deodato,1 Gabriella Macchia,1 Savino Cilla,2 Martina Pieri,3 Alice Zamagni,4 Andrea Farioli,5 Milly Buwenge,4 Gabriella Ferrandina,6,* Alessio G Morganti4,* 1Radiotherapy Unit, General Oncology Unit, Fondazione Giovanni Paolo II, Campobasso, Italy; 2Medi...

Full description

Bibliographic Details
Main Authors:	Digesù C, Deodato F, Macchia G, Cilla S, Pieri M, Zamagni A, Farioli A, Buwenge M, Ferrandina G, Morganti AG
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-10-01
Series:	Breast Cancer: Targets and Therapy
Subjects:	breast cancer radiotherapy hypofractionation retrospective study.
Online Access:	https://www.dovepress.com/hypofractionated-radiotherapy-after-conservative-surgery-may-increase--peer-reviewed-article-BCTT

Similar Items

Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond
by: Febin Antony, et al.
Published: (2024-01-01)

Hypofractionated Radiotherapy in African Cancer Centers
by: William Swanson, et al.
Published: (2021-02-01)

Conventional versus different hypofractionated radiotherapy dosage schedules in postmastectomy advanced breast cancer
by: Neeraj Jain, et al.
Published: (2022-01-01)

Efficacy and Toxicity of Hypofractionated Palliative Radiotherapy for Breast Cancer Patients with Skin Invasion
by: Talha Maqsood, et al.
Published: (2023-08-01)

Hypofractionated Radiotherapy for Post-Operative Breast Cancer Patients at Delta Hospital - an Evaluation of Clinical Experience
by: Parvin Akhter Banu, et al.
Published: (2015-01-01)

Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?
by: Sean Mahase, et al.
Published: (2020-12-01)

Intensity-Modulated Radiotherapy with Concomitant Boost After Breast Conserving Surgery: A Phase I–II Trial
by: Macchia G, et al.
Published: (2020-11-01)

Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions
by: Huayong Jiang, et al.
Published: (2021-12-01)

Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy
by: Georges Noël, et al.
Published: (2013-09-01)

Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives
by: Maria Chiara Lo Greco, et al.
Published: (2023-06-01)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
by: Ioannis M. Koukourakis, et al.
Published: (2021-09-01)

The Feasibility Study of Hypofractionated Radiotherapy with Regional Hyperthermia in Soft Tissue Sarcomas
by: Mateusz Jacek Spałek, et al.
Published: (2021-03-01)

Symptom palliation of hypofractionated radiotherapy for patients with incurable inflammatory breast cancer
by: Hoon Sik Choi, et al.
Published: (2019-06-01)

Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis
by: Dong-Yun Kim, et al.
Published: (2021-02-01)

Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review
by: Siyer Roohani, et al.
Published: (2022-09-01)

Hypofractionated Post-Prostatectomy Radiotherapy in 16 Fractions: A Single-Institution Outcome
by: Pavol Dubinsky, et al.
Published: (2023-07-01)

Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome
by: Barra S, et al.
Published: (2018-03-01)

Hypofractionated Radiotherapy for 35 Patients with Adrenal Metastases: A Single-Institution Experience
by: Zhao R, et al.
Published: (2020-11-01)

Hypofractionation: The standard for external beam breast irradiation
by: Adrian Murray Brunt, et al.
Published: (2023-06-01)

Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review
by: Lei Liu, et al.
Published: (2020-01-01)

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
by: Jiaoxue He, et al.
Published: (2023-01-01)

Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
by: Jongmoo Park, et al.
Published: (2018-10-01)

Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer
by: Janice Ser Huey Tan, et al.
Published: (2024-02-01)

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
by: Jiang Xue-song, et al.
Published: (2012-03-01)

Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results
by: Maurizio Valeriani, et al.
Published: (2022-08-01)

Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation
by: Laurence Mengue, et al.
Published: (2020-04-01)

Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer
by: Eileen Samuel, et al.
Published: (2024-02-01)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
by: Xue-Yi Xie, et al.
Published: (2022-07-01)

Malignant Pleural Mesothelioma: Preliminary Toxicity Results of Adjuvant Radiotherapy Hypofractionation in a Prospective Trial (MESO-RT)
by: Elisabetta Parisi, et al.
Published: (2023-02-01)

Comparison of peripheral leukocyte parameters in patients receiving conventionally and hypofractionated radiotherapy schemes for the treatment of newly diagnosed glioblastoma
by: Lindsey Greenlund, et al.
Published: (2023-10-01)

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall: Results of a Single-Arm Prospective Clinical Trial
by: Hanna Koseła-Paterczyk, et al.
Published: (2020-08-01)

Effect of hypofractionated radiotherapy on lung functions in breast cancer patients
by: Enass A.A. Rezk, et al.
Published: (2023-01-01)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
by: Michael Laursen, et al.
Published: (2018-06-01)

Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era
by: Cheng Huang, et al.
Published: (2024-01-01)

Efficacy and safety analysis of hypofractionated and conventional fractionated radiotherapy in postoperative breast cancer patients
by: Yongkai Lu, et al.
Published: (2024-02-01)

Treatment Outcomes after Dose-Escalated Moderately Hypofractionated Radiotherapy for Frail Patients with High-Grade Glioma
by: Nalee Kim, et al.
Published: (2023-12-01)

Hypofractionated Radiotherapy in Gynecologic Malignancies—A Peek into the Upcoming Evidence
by: Razan Amjad, et al.
Published: (2024-01-01)

Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma
by: Jiahua Lyu, et al.
Published: (2019-07-01)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review
by: Martin Schmitt, et al.
Published: (2022-08-01)

A comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients
by: Kartick Rastogi, et al.
Published: (2018-01-01)